SESSION TITLE: Fellow Case Report Poster - Critical Care I
SESSION TYPE: Affiliate Case Report Poster
PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM
INTRODUCTION: K2 is a new synthetic cannabinoid engineered to resemble marijuana and to reproduce its effects. With a potency 100 times that of marijuana, it has well described neuropsychological but less predictable physiologic manifestations when compared to marijuana. We present a case of a patient with altered sensorium and findings of global cerebral edema after K2 use.